scorecardresearch
Cadila Healthcare

Cadila Healthcare

 

More Stories on Cadila Healthcare
Zydus Cadila has stated that the targeted production of the ZyCoV-D vaccine from the Dharwad facility will be mutually agreed upon by both parties

Zydus Cadila inks deal with Shipa Medicare for ZyCoV-D COVID-19 vaccine production

Sep 24, 2021

Shilpa Medicare Limited will produce the ZyCoV-D COVID-19 vaccine at its biologics R&D and manufacturing centre in Dharwad, Karnataka

Stocks in news: Hindustan Copper, HCL Tech, Cadila Healthcare, Adani Ports and more

Stocks in news: Hindustan Copper, HCL Tech, Cadila Healthcare, Adani Ports and more

Sep 21, 2021

Closing sharply lower, the Indian equity benchmarks Sensex and Nifty, saw a major fall as the volatility index rose 12 per cent on Monday. The fall in the market is seen in line with losses across global markets as investors wait for cues from the US Federal Reserve Bank this week

Stocks in news: Wipro, Zomato, Vodafone Idea, Cadila Healthcare, Lupin and more

Stocks in news: Wipro, Zomato, Vodafone Idea, Cadila Healthcare, Lupin and more

Sep 20, 2021

On September 17, the benchmark indices ended lower after scaling record highs as investors booked profits at higher levels. After moving in a range of 866 points during the day, Sensex closed 125.27 points lower at 59,015 and Nifty slipped 44.35 points to 17,585.

With this acquisition, LIC's stake in Cadila Healthcare has increased to 5.036 per cent from 4.971 per cent earlier.

LIC acquires over 6.64 lakh shares of Cadila Healthcare, takes stake to above 5%

Sep 01, 2021

The insurance company said it acquired 6,64,104 shares of Cadila Healthcare, amounting to an additional stake of 0.065 per cent in the company.

India's daily vaccinations surpassed 10 million doses on Friday, with national vaccine production more than doubling since April and set to rise again in the coming weeks

Jump in COVID-19 vaccine supplies raises export hopes

Aug 30, 2021

After donating or selling 66 million doses to nearly 100 countries, India barred exports in the middle of April to focus on domestic immunisation as infections exploded, upsetting the inoculation plans of many African and South Asian countries

The alarm bells rang in June 2019 when Andhra Bank had initiated insolvency proceedings against Sterling Biotech

The rise and fall of the Sandesara brothers and Sterling Biotech

Aug 24, 2021

At a group level, Sterling has a debt in excess of Rs 15,000 crore. With the banks resigned to a huge haircut on loans of over Rs 8,000 crore, the future of this company is at best unknown

Cadila Healthcare share price zooms 8% after DCGI approves needle-free COVID-19 vaccine

Cadila Healthcare share price zooms 8% after DCGI approves needle-free COVID-19 vaccine

Aug 23, 2021

The company informed that the thermostability of the vaccine will help in easy transportation and storage of the vaccine and reduce any cold chain breakdown challenges leading to vaccine wastage

Stock Market Updates: Sensex up 400 points, Nifty above 16,550; Cadila Healthcare zooms 5%

Stock Market Updates: Sensex up 400 points, Nifty above 16,550; Cadila Healthcare zooms 5%

Aug 23, 2021

At 09:20 hours, the 30-share BSE index was trading 405 points or 0.73 per cent higher at 55,713.43, and the broader NSE Nifty was up 107 points or 0.65 per cent to 16,557.90

Sterling Biotech and its subsidiaries - Sterling SEZ and Sterling International - collectively owe Rs 15,000 crore to operational and financial creditors

Aurobindo Pharma, Cadila, 3 others in race to acquire Sterling Biotech

Aug 22, 2021

Last month, the liquidator had invited bids for the liquidation process of Sterling Biotech to sell it as a going concern at a reserve price of Rs 548.46 crore

On its COVID-19 portfolio, Zydus Cadila said it has undertaken research in monoclonal antibodies cocktail to neutralise COVID infection.

Zydus Cadila Q1 net profit rises 29% to Rs 587 cr, revenue up 15%

Aug 11, 2021

The pharma company's revenue from operations rose 15 per cent YoY to Rs 4,025 crore, while EBITDA jumped 18 per cent to Rs 933 crore.

Stocks in news: Zomato, Reliance Infrastructure, Cadila Healthcare, JSPL and more

Stocks in news: Zomato, Reliance Infrastructure, Cadila Healthcare, JSPL and more

Aug 11, 2021

On Tuesday, Sensex ended at a record high, tracking gains in index majors HDFC, Bharti Airtel and Infosys amid a largely positive trend in global markets